Why is the surface of an explanted implant such fragile evidence?
The surface of an explanted implant is fragile evidence because wear morphology, corrosion product, fracture features, adherent tissue and biofilm all sit within microns of the outside of the device, and none of it is robust. Wiping, scrubbing, ultrasonic cleaning and enzymatic detergent are all effective at doing exactly what they are intended to do, and every one of them removes that surface record.
Nothing in a subsequent examination recovers the surface record of an explanted implant. A cleaned explant still supports dimensional measurement, bulk material analysis and fracture path reconstruction, but questions that depend on the surface become unanswerable rather than merely harder.
What does routine processing do to an explanted implant?
Routine processing of an explanted implant is defensible for its own purpose and destructive to the forensic record. Explanted devices are commonly rinsed at the field, dropped into formalin for pathology, autoclaved before being handled outside the sterile field, or returned to the manufacturer through a complaint process with its own cleaning step, and each of those steps removes evidence.
Sterilization of an explanted implant deserves particular attention. Heat and chemical sterilization processes alter surface oxide, can degrade polymers, and remove or fix biological material in ways that are neither reversible nor obvious. An explant that went through a reprocessing cycle must be described as such, or processing artifacts get attributed to the body.
Is there a standard practice for retrieving and analyzing explanted medical devices?
Yes. ASTM F561 is the standard practice for retrieval and analysis of medical devices and the associated tissues and fluids, and much of its value is procedural rather than technical. ASTM F561 sets an order of operations, from receipt and documentation through non-destructive examination and sampling to anything destructive, and it treats tissue and fluid as part of the retrieval.
Following a published practice such as ASTM F561 also matters evidentially. An examination of an explanted device performed in an order a recognized standard describes is easier to defend than one assembled ad hoc, particularly where a step was destructive and cannot be repeated.
Why do tissue and fluid need to be collected when an implant is removed?
Tissue and fluid need to be collected when an implant is removed because the explanted device answers what happened to the device, while the tissue and fluid around it answer what happened to the patient, and they must be sampled at that procedure or not at all. Tissue for histopathology, fluid for analysis, and samples reserved for microbiology are collected in the operating theater by people who have to be told in advance.
Lost tissue is the most common irrecoverable loss in implant matters. The explanted device is kept because it is an object someone thinks to retain. The tissue is discarded because nobody asked for it, and it cannot be obtained afterward.
Who needs explant handling instructions, and what should they say?
Explant handling instructions need to reach the surgical and operating theater staff, and they should say: do not clean, do not scrub, do not autoclave, package as specified, retain every fragment, retain packaging and lot documentation. The surgical and operating theater staff are the people who can preserve an explant, and they are usually not the people instructing the investigation. Written explant handling instructions arriving before the revision procedure cost nothing and change what is later provable.
Where a revision procedure has already happened, the same explant handling instructions apply to whatever remains, and establishing where the explanted device physically sits — pathology, biomedical engineering, the manufacturer, or a disposal stream with a retention window — becomes the immediate priority.
How should the as-found state of an explanted implant be documented?
The as-found state of an explanted implant should be documented, before anything moves, with photographs of the device as removed, with orientation marked and a scale included, because those photographs are the only version of the as-found state that survives. Orientation matters: a wear stripe or corrosion pattern is interpretable only if it can be related back to how the component sat in the body, and that relationship disappears the moment the device is bagged without a note.
Imaging obtained before the revision procedure belongs to the explant retrieval record too. Radiographs, computed tomography or fluoroscopy establish component position, migration and any fracture in situ, which the explant alone cannot.
How should chain of custody be documented for an explanted implant?
Chain of custody for an explanted implant is documented transfer by transfer, recording who held the device, in what condition, in what container and when, because an explant typically passes through a hospital, sometimes a pathology department, occasionally a manufacturer’s complaint process, and eventually a laboratory, none of which share a custody system. Documenting each transfer of an explant is unglamorous and routinely decisive.
Where an explanted device went back to the manufacturer before any independent examination, that is not fatal, but it changes the posture. The examination is then of an item held by an interested party, and the handling record becomes part of what has to be established.
How can damage from removing an implant be told apart from damage that happened in the body?
Damage from removing an implant is usually distinguishable from in-service damage: a fresh cut shows bright unoxidized material and sharp margins, without the oxide, deposit or fatigue features an in-vivo surface accumulates. Damage inflicted during removal is normal and expected. Instrument marks, cut edges and scratches from extraction tools are common, and mistaking one for in-service damage is a serious error in the wrong direction.
What can a well-preserved implant retrieval prove?
With the explant uncleaned and intact, the tissue sampled, the imaging retained and the handling documented, the mechanism of an implant failure is usually determinable and the timeline can often be bounded. Without them, the honest answer is frequently that the surviving evidence no longer distinguishes between the candidate mechanisms, which is an uncomfortable position for whoever carries the burden of proof.
This article is general technical orientation, not a failure analysis, an engineering opinion, or advice on any specific matter. Determining the cause of a particular incident requires hands-on examination by a credentialed expert.